Zdrowie i gospodarka · 01/05/2009

FDA Releases Draft Guidance on Label Comprehension Studies for Nonprescription Drug Products

The Food and Drug Administration (FDA) has made available a draft guidance document that outlines recommendations for conducting label comprehension studies to evaluate consumer understanding of nonprescription drug product labeling and its impact on hypothetical use decisions.